News
Pfizer should have different top-selling drugs in 2030 with a heavier focus on oncology. The drugmaker should be more ...
Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...
The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the pharmaceutical company.
Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every year since 2009. Loss of patent-protected exclusivity for several ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company delayed the results of COVID-19 vaccine trials to influence the 2020 election.
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among senior executives at the pharma company to “deliberately slow down̶… ...
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the development of the ...
Pfizer has added another chapter to its long-running drug discovery collaboration with Chinese tech startup XtalPi, this time upgrading their molecular modeling work. The aim is to help “grasp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results